Effect of Aspirin in Vascular Surgery in Patients from a Randomized Clinical Trial (POISE-2).

B. M. Biccard,A. Sigamani,M. T. Chan,D. Sessler,A. Kurz,J. G. Tittley,T. Rapanos,J. Harlock,D. Szalay, M. E. Tiboni,E. Popova,S. M. Vasquez,B. Kabon,M. Amir,M. Mrkobrada, B. R. Mehra, H. El Beheiry, E. Mata,B. Tena, S. Sabate, M. K. Zainal Abidin, V. R. Shah, K. Balasubramanian,P. J. Devereaux

British Journal of Surgery（2018）SCI 1区

Cited 28|Views22

Abstract

Background: In the POISE-2 (PeriOperative ISchemic Evaluation 2) trial, perioperative aspirin did not reduce cardiovascular events, but increased major bleeding. There remains uncertainty regarding the effect of perioperative aspirin in patients undergoing vascular surgery. The aim of this substudy was to determine whether there is a subgroup effect of initiating or continuing aspirin in patients undergoing vascular surgery. Methods: POISE-2 was a blinded, randomized trial of patients having non-cardiac surgery. Patients were assigned to perioperative aspirin or placebo. The primary outcome was a composite of death or myocardial infarction at 30days. Secondary outcomes included: vascular occlusive complications (a composite of amputation and peripheral arterial thrombosis) and major or life-threatening bleeding. Results: Of 10010 patients in POISE-2, 603 underwent vascular surgery, 319 in the continuation and 284 in the initiation stratum. Some 272 patients had vascular surgery for occlusive disease and 265 had aneurysm surgery. The primary outcome occurred in 13.7 per cent of patients having aneurysm repair allocated to aspirin and 9.0 per cent who had placebo (hazard ratio (HR) 1.48, 95 per cent c.i. 0.71 to 3.09). Among patients who had surgery for occlusive vascular disease, 15.8 per cent allocated to aspirin and 13.6 per cent on placebo had the primary outcome (FIR 1.16,0.62 to 2.17). There was no interaction with the primary outcome for type of surgery (P = 0.294) or aspirin stratum (P = 0.623). There was no interaction for vascular occlusive complications (P=0.413) or bleeding (P= 0.900) for vascular compared with non-vascular surgery. Conclusion: This study suggests that the overall POISE-2 results apply to vascular surgery. Perioperative withdrawal of chronic aspirin therapy did not increase cardiovascular or vascular occlusive complications.

Translated text

Key words

Postoperative Complications,Perioperative

求助PDF

上传PDF

Bibtex

AI Read Science

AI Summary

AI Summary is the key point extracted automatically understanding the full text of the paper, including the background, methods, results, conclusions, icons and other key content, so that you can get the outline of the paper at a glance.

Example

Background

Key content

Introduction

Methods

Results

Related work

Fund

Key content

Pretraining has recently greatly promoted the development of natural language processing (NLP)
We show that M6 outperforms the baselines in multimodal downstream tasks, and the large M6 with 10 parameters can reach a better performance
We propose a method called M6 that is able to process information of multiple modalities and perform both single-modal and cross-modal understanding and generation
The model is scaled to large model with 10 billion parameters with sophisticated deployment, and the 10 -parameter M6-large is the largest pretrained model in Chinese
Experimental results show that our proposed M6 outperforms the baseline in a number of downstream tasks concerning both single modality and multiple modalities We will continue the pretraining of extremely large models by increasing data to explore the limit of its performance

Upload PDF to Generate Summary

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper